Overview Financials News + Filings Key Docs Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Inv. presentation Quarterly results
|
Humacyte, Inc.
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
10/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/21/2023 |
4
| Niklason Laura E (President, CEO and Director) has filed a Form 4 on Humacyte, Inc.
Txns:
| Sold 570,174 shares
@ $3.68, valued at
$2.1M
Sold 626,979 shares
@ $3.57, valued at
$2.2M
Sold 602,443 shares
@ $3.39, valued at
$2M
|
|
08/21/2023 |
4
| Dougan Brady W (Director) has filed a Form 4 on Humacyte, Inc.
Txns:
| Sold 570,174 shares
@ $3.68, valued at
$2.1M
Sold 626,979 shares
@ $3.57, valued at
$2.2M
Sold 602,443 shares
@ $3.39, valued at
$2M
|
|
08/21/2023 |
4
| Ayabudge LLC (10% Owner) has filed a Form 4 on Humacyte, Inc.
Txns:
| Sold 570,174 shares
@ $3.68, valued at
$2.1M
Sold 626,979 shares
@ $3.57, valued at
$2.2M
Sold 602,443 shares
@ $3.39, valued at
$2M
|
|
06/16/2023 |
4
| Brown Emery N. (Director) has filed a Form 4 on Humacyte, Inc.
Txns:
| Granted 8,500 options to buy
@ $3.35, valued at
$28.5k
|
|
06/16/2023 |
4
| Wallace Max N. (Director) has filed a Form 4 on Humacyte, Inc.
Txns:
| Granted 8,500 options to buy
@ $3.35, valued at
$28.5k
|
|
06/16/2023 |
4
| Green Charles Bruce (Director) has filed a Form 4 on Humacyte, Inc.
Txns:
| Granted 8,500 options to buy
@ $3.35, valued at
$28.5k
|
|
06/16/2023 |
4
| Dougan Brady W (10% Owner) has filed a Form 4 on Humacyte, Inc.
Txns:
| Granted 8,500 options to buy
@ $3.35, valued at
$28.5k
|
|
06/16/2023 |
4
| Sebelius Kathleen (Director) has filed a Form 4 on Humacyte, Inc.
Txns:
| Granted 8,500 options to buy
@ $3.35, valued at
$28.5k
|
|
06/16/2023 |
4
| Constantino Michael T. (Director) has filed a Form 4 on Humacyte, Inc.
Txns:
| Granted 8,500 options to buy
@ $3.35, valued at
$28.5k
|
|
06/16/2023 |
4
| Pope Todd (Director) has filed a Form 4 on Humacyte, Inc.
Txns:
| Granted 8,500 options to buy
@ $3.35, valued at
$28.5k
|
|
06/16/2023 |
4
| Binder Gordon M (Director) has filed a Form 4 on Humacyte, Inc.
Txns:
| Granted 8,500 options to buy
@ $3.35, valued at
$28.5k
|
|
06/16/2023 |
4
| Shukla Rajiv (Director) has filed a Form 4 on Humacyte, Inc.
Txns:
| Granted 8,500 options to buy
@ $3.35, valued at
$28.5k
|
|
06/16/2023 |
4
| Windham-Bannister Susan Richards (Director) has filed a Form 4 on Humacyte, Inc.
Txns:
| Granted 8,500 options to buy
@ $3.35, valued at
$28.5k
|
|
06/16/2023 |
4
| Seimetz Diane (Director) has filed a Form 4 on Humacyte, Inc.
Txns:
| Granted 8,500 options to buy
@ $3.35, valued at
$28.5k
|
|
06/16/2023 |
4
| Niklason Laura E (President, CEO and Director) has filed a Form 4 on Humacyte, Inc.
Txns:
| Granted 8,500 options to buy
@ $3.35, valued at
$28.5k
|
|
06/16/2023 |
4
| Niklason Laura E (President, CEO and Director) has filed a Form 4 on Humacyte, Inc.
Txns:
| Sold 500,000 shares
@ $3.1175, valued at
$1.6M
|
|
06/16/2023 |
4
| Dougan Brady W (10% Owner) has filed a Form 4 on Humacyte, Inc.
Txns:
| Sold 500,000 shares
@ $3.1175, valued at
$1.6M
|
|
06/16/2023 |
4
| Ayabudge LLC (10% Owner) has filed a Form 4 on Humacyte, Inc.
Txns:
| Sold 500,000 shares
@ $3.1175, valued at
$1.6M
|
|
05/26/2023 |
4
| Niklason Laura E (President, CEO and Director) has filed a Form 4 on Humacyte, Inc.
Txns:
| Sold 2,625,000 shares
@ $2.75, valued at
$7.2M
|
|
05/26/2023 |
4
| Prichard Heather Ledbetter (COO) has filed a Form 4 on Humacyte, Inc.
Txns:
| Sold 13,789 shares
@ $4.14, valued at
$57.1k
Sold 9,613 shares
@ $3.83, valued at
$36.8k
Exercised 13,789 options to buy
@ $1.19, valued at
$16.4k
Exercised 64,990 options to buy
@ $1.19, valued at
$77.3k
|
|
05/26/2023 |
4
| Dougan Brady W (10% Owner) has filed a Form 4 on Humacyte, Inc.
Txns:
| Sold 2,625,000 shares
@ $2.75, valued at
$7.2M
|
|
05/26/2023 |
4
| Ayabudge LLC (10% Owner) has filed a Form 4 on Humacyte, Inc.
Txns:
| Sold 2,625,000 shares
@ $2.75, valued at
$7.2M
|
|
05/19/2023 |
4
| Constantino Michael T. (Director) has filed a Form 4 on Humacyte, Inc.
Txns:
| Bought 4,750 shares
@ $4.18, valued at
$19.9k
|
|
03/02/2023 |
4
| Dougan Brady W (10% Owner) has filed a Form 4 on Humacyte, Inc.
Txns:
| Exercised 100,000 options to buy
@ $1.19, valued at
$119k
|
|
03/02/2023 |
4
| Niklason Laura E (President, CEO and Director) has filed a Form 4 on Humacyte, Inc.
Txns:
| Exercised 100,000 options to buy
@ $1.19, valued at
$119k
|
|
12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/15/2022 |
4
| Scheessele William John (Chief Commercial Officer) has filed a Form 4 on Humacyte, Inc.
Txns:
| Bought 5,000 shares
@ $3.09, valued at
$15.5k
|
|
|
|
|